News Notification

The Brigham and Dana-Farber Board Review in Hematology and Oncology 2018

2380 views Tags: CME Brigham Board Review

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. Relevant topics are addressed in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

* Date of Original Release: June 30, 2018

LEARNING OBJECTIVES

After viewing this program, participants should be able to:

  • Apply current/recommended Hematology and Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
  • Identify/apply current therapeutic options for for specific Hematologic and Oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
  • Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

0 0 votes
Article Rating

THE BRIGHAM AND DANA-FARBER BOARD REVIEW IN HEMATOLOGY AND ONCOLOGY TOPICS

1. Molecular Genetics of Cancer – Nikhil Wagle, MD

2. Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD

3. Infections in Cancer Patients – Lindsey Baden, MD

4. Symptom Management in Patients with Cancer – Janet L. Abrahm, MD

5. Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD

6. Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

7. Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

8. Acute Leukemias – Daniel J. DeAngelo, MD, PhD

9. Myelodysplastic Syndrome – David P. Steensma, MD

10. Chronic Myelogenous Leukemia – Joseph H. Antin, MD

11. Myeloproliferative Syndromes – Ann M. Mullally, MD

12. Multiple Myeloma – Kenneth C. Anderson, MD

13. Waldenstrom Macroglobulinemia, Amyloidosis – Irene M. Ghobrial, MD

14. Low Grade Lymphomas – Caron A. Jacobson, MD

15. High Grade Lymphomas – Eric D. Jacobsen, MD

16. Hodgkin’s Lymphoma – Ann S. LaCasce, MD

17. Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

18. Head and Neck Cancer – Robert I. Haddad, MD

19. Natural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD

20. Non Small Cell Lung Cancer – Mark Awad, MD, PhD

21. Mesothelioma and Thymoma – David M. Jackman, MD

22. Thyroid Cancer – Jochen Lorch, MD

23. Carcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD

24. Esophageal and Gastric Cancer – Peter C. Enzinger, MD

25. Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD

26. Anal Cancers – Robert J. Mayer, MD

27. Colorectal Cancers – Robert J. Mayer, MD

28. Gastrointestinal Cancer – Genetic Syndromes – Matthew Yurgelun, MD

29. Renal and Bladder Cancer – Toni K. Choueiri, MD

30. Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD

31. Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD

32. Melanoma – F. Stephen Hodi, MD

33. Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD

34. Ovarian Cancer – Ursula A. Matulonis, MD

35. Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

36. Neuro-oncology – David A. Reardon, MD

37. Breast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH

38. Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD

39. Management for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD

40. Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

41. Hematopoiesis and Cytokines – David T. Scadden, MD

42. Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD

43. Congenital Bone Marrow Failure – David A. Williams, MD

44. Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD

45. Anemia: An Overview – Ronald P. McCaffrey, MD

46. Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD

47. Immune Hemolytic Anemia – Richard M. Kaufman, MD

48. Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

49. Sickle Cell Disease – Maureen M. Achebe, MD, MPH

50. Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

51. Disorders of Neutrophils – Nancy Berliner, MD

52. Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

53. Hemophilia – Aric D. Parnes, MD

54. Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH

55. Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

56. New Oral Anticoagulants – Jean M. Connors, MD

57. Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
error: Content is protected !!